Cover Image

Bias in Meta-Analytic Modeling of Surrogate Endpoints in Cancer Screening Trials

Fuente: arXiv

Saved in:

Bibliographic Details
Main Authors:	Long, James P., Roy, Abhishikta, Irajizad, Ehsan, Do, Kim-Anh, Shen, Yu
Format:	Preprint
Published:	2025
Subjects:	Methodology Applications
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Evaluation of Surrogate Endpoints Based on Meta-Analysis with Surrogate Indices
by: Stijven, Florian, et al.
Published: (2025)

Correcting for Missing Data When Evaluating Surrogate Markers in a Clinical Trial
by: Lotspeich, Sarah C., et al.
Published: (2026)

Tutorial for Surrogate Endpoint Validation Using Joint modeling and Mediation Analysis
by: Coent, Quentin Le, et al.
Published: (2025)

Fragility Index for Time-to-Event Endpoints in Single-Arm Clinical Trials
by: Maity, Arnab Kumar, et al.
Published: (2024)

A Reflection on the Impact of Misspecifying Unidentifiable Causal Inference Models in Surrogate Endpoint Evaluation
by: Deliorman, Gokce, et al.
Published: (2024)

A Utility Score Framework for Dose Optimization Studies with Binary Efficacy-Safety Endpoints: Sample Size Determination and Bias Characterization
by: Gu, Xuemin, et al.
Published: (2026)

Toward Valid Generative Clinical Trial Data with Survival Endpoints
by: Chassat, Perrine, et al.
Published: (2025)

Study Duration Prediction for Clinical Trials with Time-to-Event Endpoints Using Mixture Distributions Accounting for Heterogeneous Population
by: Zhang, Hong, et al.
Published: (2023)

Power and Sample Size Calculations for Bayes Factors in two-arm clinical Phase II Trials with binary Endpoints
by: Kelter, Riko
Published: (2026)

Optimal sequential two-stage Bayes Factor Design for two-arm clinical Phase II Trials with binary Endpoints
by: Kelter, Riko
Published: (2026)

Bayesian compositional regression with flexible microbiome feature aggregation and selection
by: Saha, Satabdi, et al.
Published: (2024)

Addressing Outcome Reporting Bias in Meta-analysis: A Selection Model Perspective
by: Saracini, Alessandra Gaia, et al.
Published: (2024)

Evaluating the Surrogate Index as a Decision-Making Tool Using 200 A/B Tests at Netflix
by: Zhang, Vickie, et al.
Published: (2023)

Adjusting for Selection Bias Due to Missing Eligibility Criteria in Emulated Target Trials
by: Benz, Luke, et al.
Published: (2024)

Cost-Effectiveness Analysis for Disease Prevention -- A Case Study on Colorectal Cancer Screening
by: Xiong, Yi, et al.
Published: (2024)

Multi-Dimensional Composite Endpoint Analysis via the Choquet Integral: Block Recurrent Encoding and Comparative Advantage Mapping
by: Tanboga, Ibrahim Halil
Published: (2026)

Two-stage Adaptive Design Cluster Randomised Trials
by: Watson, Samuel I., et al.
Published: (2026)

A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials
by: Komaki, Moka, et al.
Published: (2025)

Dynamic Prediction of the Target Survival Time in Metastatic Solid Tumor Cancer Clinical Trials
by: Wang, Sidi, et al.
Published: (2026)

Competing Risk Analysis in Cardiovascular Outcome Trials: A Simulation Comparison of Cox and Fine-Gray Models
by: Wang, Tuo, et al.
Published: (2026)

RISE: Two-Stage Rank-Based Identification of High-Dimensional Surrogate Markers Applied to Vaccinology
by: Hughes, Arthur, et al.
Published: (2025)

Optimal Sampling for Generalized Linear Model under Measurement Constraint with Surrogate Variables
by: Shen, Yixin, et al.
Published: (2025)

SIMBA -- A Bayesian Decision Framework for the Identification of Optimal Biomarker Subgroups for Cancer Basket Clinical Trials
by: Yuan, Shijie, et al.
Published: (2025)

Mixture of Finite Mixtures Model for Basket Trial
by: Geng, Junxian, et al.
Published: (2020)

Surrogate modeling with functional nonlinear autoregressive models (F-NARX)
by: Schär, Styfen, et al.
Published: (2024)

Modeling Time-Varying Effects of Mobile Health Interventions Using Longitudinal Functional Data from HeartSteps Micro-Randomized Trial
by: Yu, Jiaxin, et al.
Published: (2024)

Meta-analysis of Censored Adverse Events
by: Qi, Xinyue, et al.
Published: (2021)

Estimation and Inference for Win Measures with Multiple Ordinal Endpoints Subject to Missingness
by: Liu, Yi, et al.
Published: (2026)

Bayesian Spatial Point Process Modeling for Cluster Randomized Trials
by: Lee, Jooyeon, et al.
Published: (2025)

Bayesian Graphical High-Dimensional Time Series Models for Detecting Structural Changes
by: Ghosh, Shuvrarghya, et al.
Published: (2025)

A Workflow for Evaluating Regional Treatment Effect Heterogeneity in Multi-Regional Clinical Trials
by: Zhang, Cong, et al.
Published: (2026)

Evaluating Bias Reduction Methods in Binary Emax Model for Reliable Dose-Response Estimation
by: Zhang, Jiangshan, et al.
Published: (2025)

Estimation and Inference of the Win Ratio for Two Hierarchical Endpoints Subject to Censoring and Missing Data
by: Liu, Yi, et al.
Published: (2026)

Eligibility-Aware Evidence Synthesis: An Agentic Framework for Clinical Trial Meta-Analysis
by: Zhao, Yao, et al.
Published: (2026)

Semiparametric Piecewise Accelerated Failure Time Model for the Analysis of Immune-Oncology Clinical Trials
by: Sunami, Hisato, et al.
Published: (2024)

Bias Mitigation in Matched Observational Studies with Continuous Treatments: Calipered Non-Bipartite Matching and Bias-Corrected Estimation and Inference
by: Frazier, Anthony, et al.
Published: (2024)

Semiparametric Modelling of Cancer Mortality Trends in Colombia
by: Buitrago, Lina, et al.
Published: (2024)

A Bayesian Framework for Latent Compliance Modeling in Cluster Randomized Trials with One-Sided Noncompliance
by: Sisti, Anthony, et al.
Published: (2025)

Considerations for the Integration of Randomized Controlled Trials and Real-World Data
by: Qiu, Sky, et al.
Published: (2026)

MUCE: Bayesian Hierarchical Modeling for the Design and Analysis of Phase 1b Multiple Expansion Cohort Trials
by: Lyu, Jiaying, et al.
Published: (2020)